TrialInternational journal of hematology2018

Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.

Atsushi Isoda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.